| Symbol | BJDX |
|---|---|
| Name | BLUEJAY DIAGNOSTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 360 MASSACHUSETTS AVENUE,SUITE 203, ACTON, Massachusetts, 01720, United States |
| Telephone | +1 844 - 327-7078 |
| Fax | — |
| — | |
| Website | https://www.bluejaydx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001704287 |
| Description | Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide convenience, timeliness, compliance and low cost to physicians and patients in areas where timeliness of the initial triage assessment has a high impact on course of treatment. Additional info from NASDAQ: |
(85% Positive) BLUEJAY DIAGNOSTICS, INC. (BJDX) Provides Update on systems for federal healthcare distribution
Read moreBluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Read moreDirector ZEIDMAN FRED S 🟢 acquired 100.0K shares (1 derivative) of Bluejay Diagnostics, Inc. (BJDX) at $2.08 Transaction Date: Aug 17, 2026 | Filing ID: 001127
Read moreDirector Wurth Douglas Clark 🟢 acquired 100.0K shares (1 derivative) of Bluejay Diagnostics, Inc. (BJDX) at $2.08 Transaction Date: Aug 17, 2026 | Filing ID: 001126
Read moreDirector Dey Indranil 🟢 acquired 28.0K shares of Bluejay Diagnostics, Inc. (BJDX) Transaction Date: Aug 17, 2026 | Filing ID: 001124
Read moreDirector CHASE DONALD R 🟢 acquired 100.0K shares (1 derivative) of Bluejay Diagnostics, Inc. (BJDX) at $2.08 Transaction Date: Aug 17, 2026 | Filing ID: 001123
Read moreNew Form SCHEDULE 13G - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003556 <b>Size:</b> 10 KB
Read moreNew Form SCHEDULE 13G - Bluejay Diagnostics, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001493152-26-037644 <b>Size:</b> 11 KB
Read more(70% Positive) BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Enrollment Update for million Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations
Read moreBluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07425587 | Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study | — | Sepsis, Septic Shock | Recruiting | 2026-05-04 | 2026-12-30 | ClinicalTrials.gov |
| NCT06654895 | Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study | — | Sepsis, Septic Shock | Active_Not_Recruiting | 2024-11-12 | 2026-09-30 | ClinicalTrials.gov |
| NCT06181604 | Multicenter Symphony IL-6 Monitoring Sepsis ICU Study | — | Sepsis | Completed | 2024-01-12 | 2024-07-12 | ClinicalTrials.gov |
| NCT05665153 | Symphony IL-6 Study in Patients at Risk of Severe Sepsis | — | Severe Sepsis | Unknown | 2022-11-22 | 2024-11-21 | ClinicalTrials.gov |
| NCT05048888 | Symphony IL-6 Reference Range Study | — | Sepsis | Unknown | 2021-08-31 | 2024-03-30 | ClinicalTrials.gov |
| NCT05060250 | Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis … | — | Severe Sepsis | Unknown | 2021-08-31 | 2024-12-31 | ClinicalTrials.gov |
| NCT05048927 | Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis | — | Severe Sepsis | Unknown | 2021-08-31 | 2024-12-31 | ClinicalTrials.gov |